Skip to main content
Top

Drugs

Issue 10/2023

Content (12 Articles)

New Pharmacologic Approaches to the Treatment of Bipolar Depression

Kamyar Keramatian, Trisha Chakrabarty, Anais DuBow, Gayatri Saraf, Lakshmi N. Yatham

Targeting IL-23 for IBD: Rationale and Progress to Date

Sudheer K. Vuyyuru, Lisa M. Shackelton, Jurij Hanzel, Christopher Ma, Vipul Jairath, Brian G. Feagan

Acute Graft-versus-Host Disease: An Update on New Treatment Options

Dilan A. Patel, Mallory Crain, Iskra Pusic, Mark A. Schroeder

The Effect of Biological Treatment on Fatigue in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

Berit Mære Skjellerudsveen, Inger Marie Skoie, Ingvild Dalen, Tore Grimstad, Roald Omdal

Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes

James E. Frampton

Leniolisib: First Approval

Sean Duggan, Zaina T. Al-Salama

Correction to: Efanesoctocog Alfa: First Approval

  • Open Access
  • Correction

Susan J. Keam

Correction to: Sparsentan: First Approval

  • Open Access
  • Correction

Yahiya Y. Syed

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images